KaydedilenlerDerginizi ekleyin

Dergiler / Klinik Psikofarmakoloji Bülteni / 2015 / Cilt: 25 - Sayı: 1

Panic disorder induced by a herbal product containing sibutramine: Case series with review of literature

Defne ERASLAN
Aylin ÇOBAN AKSOY
Erhan ERTEKİN
Sayfa
74–77
Yayın Tarihi
2022-10-17
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

In this report, we present three cases where panic attackswere associated with the use of a product and persisted even long after its discontinuation.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Sibutramine is a serotonin and noradrenaline reuptake inhibitor which has been used for weightloss in obese patients.
📊
Temel Bulgular & Veri:There are slimming products on the market claiming to be natural whichnevertheless contain sibutramine.
💡
Sonuç & Katkı:In this report, we present three cases where panic attackswere associated with the use of a product and persisted even long after its discontinuation.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Sibutramine is a serotonin and noradrenaline reuptake inhibitor which has been used for weightloss in obese patients. There are slimming products on the market claiming to be natural whichnevertheless contain sibutramine. In this report, we present three cases where panic attackswere associated with the use of a product and persisted even long after its discontinuation.

🔖

Bu Makaleye Atıf Yap

ERASLAN, D., AKSOY, A. Ç., ERTEKİN, E. (2022). Panic disorder induced by a herbal product containing sibutramine: Case series with review of literature. Klinik Psikofarmakoloji Bülteni, Cilt: 25 - Sayı: 1, 74–77. https://ajindex.com/articles/573954

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (3)

  1. Glandt M, Raz I. Present and future: pharmacologic treatment of obesity. J Obes 2011; Article ID 636181. doi:10.155/2011/636181
  2. Jung J, Hermanns-Clausen M, Weinmann W. Anorectic sibutramine detected in a Chinese herbal drug for weight loss. Forensic Sci Int 2006;161(2-3):221-2. [CrossRef] 3. Fu PK, Hsu HY, Wang PY. Transient global amnesia after taking sibutramine: a case report. Neurologist 2010;16(2):129- 31. [CrossRef] 4. Taflinski T, Chojnacka J. Sibutramine-associated psychotic episode (letter). Am J Psychiatry 2000;157(12):2057-8. [CrossRef] 5. Fernandez P, Peiro AM. A Sibutramine-induced delusional disorder relapse. J Neuropsychiatry Clin Neurosci 2007;19(1):88-9. [CrossRef] 6. Benazzi F. Organic hypomania secondary to sibutramine- citalopram interaction. J Clin Psychiatry 2002;63(2):165. [CrossRef] 7. Cordeiro Q, Vallada H. Sibutramine-induced mania episode in a bipolar patient. Int J Neuropsychopharmacol 2002; 5(3):283-4. [CrossRef] 8. Yim KM, Ng HW, Chan CK, Yip G, Lau FL. Sibutramine- induced acute myocardial infarction in a young lady. Clin Toxicol (Phila) 2008;46(9):877-9. [CrossRef] 9. Binkley K, Knowles SR. Sibutramine and panic attacks. Am J Psychiatry 2002;159(10):1793-4. [CrossRef] 10. Fiorentini S, Russo D, D’Amato A, Limpido L, Bersani G. Sibutramine-related panic attack: a clinical case of apparent resolution with paroxetine. Riv Psichiatr 2009;44(1):64-7
  3. Harrison-Woolrych M, Ashton J, Herbison P. Fatal and non-fatal cardiovascular events in a general population prescribed sibutramine in New Zealand: a prospective cohort study. Drug Saf 2010;33(7):605-13. [CrossRef] 12. James WP, Caterson ID, Coutinho W, Finer N, Van Gaal LF, Maggioni AP, et al. SCOUT Investigators. Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. N Engl J Med 2010;363(10):905-17. [CrossRef] 13. Ehlers A, Mayou RA, Sprigings DC, Birkhead J. Psychological and perceptual factors associated with arrhythmias and benign palpitations. Psychosom Med 2000;62(5):693-702. [CrossRef] 14. O’Brien MS, Wu LT, Anthony JC. Cocaine use and the occurrence of panic attacks in the community: a case-crossover approach. Subst Use Misuse 2005;40(3):285-97. [CrossRef] 15. Masdrakis VG, Papakostas YG, Vaidakis N, Papageorgiou C, Pehlivanidis A. Caffeine challenge in patients with panic disorder: baseline differences between those who panic and those who do not. Depress Anxiety 2008;25(9):E72-9. [CrossRef] 16. Iwanami A, Kuwakado D, Otsubo T, Ishono